Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Preparation and use of aP2 inhibitors in diabetes and related conditions

Nov. 8, 2000

Peptides from P&G are selective MC3 and/or MC4 receptor ligands

Nov. 8, 2000

Roche's new antidiabetic agents act as glucokinase activators

Nov. 8, 2000

Array BioPharma and Amgen to collaborate on phosphatase inhibitors

Nov. 8, 2000

Amylin moves AC-2993 to phase II for type 2 diabetes

Nov. 8, 2000

Recent AHP patent describes calcitonin inducers particularly useful for osteoporosis

Nov. 7, 2000

Novel series from AHP with FSH-antagonist activity and utility as contraceptives

Nov. 7, 2000

Pharmacokinetics, distribution and elimination of human CXC chemokine in mice

Nov. 7, 2000

DIRECT trial begins for prevention and progression of retinopathy in diabetic patients

Nov. 7, 2000

Recombinant human NGF safe but ineffective in diabetic polyneuropathy

Nov. 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
EASL spotlight: TUNE-401 advances epigenetic silencing in HBV
BioWorld
Several presentations at EASL highlight a new generation of therapies coming into view, with the work from Tune Therapeutics Inc. standing out as one of the most...